Cent Eur J Public Health 2022, 30(2):67-73 | DOI: 10.21101/cejph.a7094

Asbestos danger in central Europe is not yet over – the situation in the Czech Republic

Miroslav Urban1, Daniela Pelclová2, Pavel Urban1, Michael Vít1, Peter Urban1, Zdenka Fenclová1, 2
1 Centre of Occupational Health, National Institute of Public Health, Prague, Czech Republic
2 Department of Occupational Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic

Objectives: In the Czech Republic, asbestos has been classified as a known human carcinogen since 1984. The use of asbestos-containing products was limited to scenarios where the use of other materials was not possible. Since 1997, the manufacture of asbestos materials has been forbidden, and in 1999, the import, manufacture and distribution of all types of asbestos fibres was legally banned by Act No. 157/1998 Coll. Although the use of asbestos is forbidden, the risk of exposure still exists given the ongoing demolition and reconstruction of buildings in which asbestos has been used. In addition, a novel risk has arisen through the quarrying of asbestos-containing aggregates and their subsequent use. The aim of this paper was to describe and evaluate asbestos in terms of history, legislation, current risk of occupational exposure and its health consequences in the Czech Republic over the last three decades.

Methods: This retrospective descriptive study used the collected data on occupational exposure and occupational diseases. The counts of workers occupationally exposed to asbestos were obtained from the Registry of Work Categorization; the numbers and structure of occupational diseases caused by asbestos were taken from the Czech National Registry of Occupational Diseases. Data on the total number of mesothelioma cases recorded in the Czech National Cancer Registry was provided by the Institute of Health Information and Statistics of the Czech Republic.

Results: A total of 13,112 subjects were registered as occupationally exposed to asbestos during the period 2001-2020. A total of 687 cases of asbestos-related occupational diseases were reported in the period 1991-2020 in the Czech Republic, comprising 178 cases of asbestosis, 250 cases of pleural hyalinosis, 168 cases of pleural or peritoneal mesothelioma, 90 cases of lung cancer, and one case of laryngeal cancer. The data from the Czech National Cancer Registry, available for a shorter period (1991-2018), reveal 1,389 cases of mesothelioma, of which only ~11% were recognised as occupational, despite the fact that the occupational causality of mesotheliomas is estimated to be up to 90% of mesotheliomas. Moreover, the latency of mesotheliomas since the last occupational exposure reached up to 50 years and this trend is still slightly increasing, unlike asbestosis, where a high cumulative dose of inhaled asbestos is needed. The real proportion of occupational lung cancers may obviously be even higher, especially in smokers, where occupational causes including asbestos are not suspected by most physicians.

Conclusion: Czech data on asbestos-related occupational diseases, especially cancers, are grossly underestimated, which is most apparent through the low proportion of mesotheliomas diagnosed as occupational. Asbestos materials in older buildings remained in situ and may represent a danger during reconstruction works. The current source of exposure appears to be quarrying of asbestos-containing aggregate and its subsequent use. Awareness of the professional community is therefore crucial, not only for the possibility of compensating those affected, but also for the early detection of the diseases through the dispensary of exposed persons.

Keywords: asbestos, asbestos ban, asbestos-related diseases, unrecognised occupational diseases, work categorization

Received: October 26, 2021; Revised: May 6, 2022; Accepted: May 6, 2022; Published: June 30, 2022  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Urban M, Pelclová D, Urban P, Vít M, Urban P, Fenclová Z. Asbestos danger in central Europe is not yet over – the situation in the Czech Republic. Cent Eur J Public Health. 2022;30(2):67-73. doi: 10.21101/cejph.a7094. PubMed PMID: 35876593.
Download citation

References

  1. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Asbestos (chrysotile, amosite, crocidolite, tremolite, actinolite and anthophyllite). IARC Monogr Eval Carcinog Risks Hum. 2012;100C:219-309.
  2. Pelclova D. Pneumoconiosis - a disease of mineral dusts. Olomouc: Solen; 2018. (In Czech.)
  3. Longo WE, Rigler MW, Slade J. Crocidolite asbestos fibers in smoke from original Kent cigarettes. Cancer Res. 1995;55(11):2232-5.
  4. King D. History of asbestos [Internet]. Orlando: The Mesothelioma Center; 2021 [cited 2021 Sep 3]. Available from: https://www.asbestos.com/asbestos/history/.
  5. U.S. Department of Health and Human Services. Asbestos fibers and other elongate mineral particles: state of the science and roadmap for research. Curr Intell Bull. 2011;(62):1-153.
  6. De Vuyst P, Karjalainen A, Dumortier P, Pairon J-C, Monsó E, Brochard P, et al. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. Eur Respir J. 1998;11(6):1416-26. Go to original source... Go to PubMed...
  7. Selby K. Asbestosis [Internet]. Orlando: The Mesothelioma Center; 2021 [cited 2021 Sep 3]. Available from: https://www.asbestos.com/asbestosis/.
  8. Markowitz S. Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues. Semin Respir Crit Care Med. 2015;36(3):334-46. Go to original source... Go to PubMed...
  9. Klebe S, Leigh J, Henderson DW, Nurminen M. Asbestos, smoking and lung cancer: an update. Int J Environ Res Public Health. 2020;17(1):258. doi: 10.3390/ijerph17010258. Go to original source... Go to PubMed...
  10. Oksa P, Wolff H, Vehmas T, Pallasaho P, Frilander H, editors. Asbestos, asbestosis, and cancer: Helsinki criteria for diagnosis and attribution 2014. Helsinki: Finnish Institute of Occupational Health; 2014.
  11. Langseth H, Johansen BV, Nesland JM, Kjaerheim K. Asbestos fibers in ovarian tissue from Norwegian pulp and paper workers. Int J Gynecol Cancer. 2007;17(1):44-9. Go to original source... Go to PubMed...
  12. Kazmarova H, Kotlik B, Lipsova V, Urban P, Vit M. Asbestos National Profile of the Czech Republic. Prague: National Institute of Public Health; 2019. (In Czech.)
  13. Pelclová D, Fenclová Z, Urban P. Asbestos exposure, legislation and diseases in the Czech Republic. Cent Eur J Public Health. 2007;15(3):99-102. Go to original source... Go to PubMed...
  14. Government Decree No. 290, 1995, wherein is set the list of occupational diseases, as amended. Sbírka zákonù ÈR. 1995 Dec 15; Pt 76:3969-78. (In Czech.)
  15. Pelclova D, Fenclova Z, Urban P. Occupational cancer in the Czech Republic - a tip of the iceberg? Eur J Oncol. 2011;16(3):149-61.
  16. International Agency for Research on Cancer. IARC cancer mortality database [Internet]. Lyon: IARC; 2019 [cited 2021 Sep 3]. Available from: https://www-dep.iarc.fr/WHOdb/WHOdb.htm.
  17. Soeberg MJ, Leigh J, van Zandwijk N. Malignant mesothelioma in Australia 2015: current incidence and asbestos exposure trends. J Toxicol Environ Health B Crit Rev. 2016;19(5-6):173-89. Go to original source... Go to PubMed...
  18. Takala J. Eliminating occupational cancer in Europe and globally: working paper 2015.10. Brussels: ETUI; 2015.
  19. European Communities. Work and health in the EU: a statistical portrait: data 1994-2002. Luxembourg: Office for Official Publications of the European Communities; 2004.
  20. Swiatkowska B, Szeszenia-Dabrowska N. Long-term epidemiological observation of asbestos-related diseases in Poland, 1970-2015. Occup Med (Lond). 2017;67(3):182-7. Go to original source... Go to PubMed...
  21. Gogou E, Hatzoglou C, Zarogiannis SG, Malli F, Jagirdar RM, Gourgoulianis KI. Mesothelioma mortality rates in Greece for the period 2005-2015 is increased compared to previous decades. Medicina (Kaunas). 2019;55(8):419. doi:10.3390/medicina55080419. Go to original source... Go to PubMed...
  22. Marinaccio A, Binazzi A, Gauzillo G, Cavone D, Zotti RD, Ferrante P, et al. Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register. Eur J Cancer. 2007;43(18):2722-8. Go to original source... Go to PubMed...
  23. Hilliard AK, Lovett JK, McGavin CR. The rise and fall in incidence of malignant mesothelioma from a British Naval Dockyard, 1979-1999. Occup Med (Lond). 2003;53(3):209-12. Go to original source... Go to PubMed...
  24. Tischoff I, Tannapfel A. Mesotheliom. Pathologe. 2017;38(6):547-60. (In German.) Go to original source... Go to PubMed...
  25. Janosikova M, Nakladalova M, Stepanek L, Borikova A, Vildova H, Fosum M. Occurrence of asbestos-related occupational diseases in the Czech Republic in the last 20 years. Cent Eur J Public Health. 2020;28(Suppl):S37-42. Go to original source... Go to PubMed...
  26. Van Gerwen M, Alpert N, Flores R, Taioli E. An overview of existing mesothelioma registries worldwide, and the need for a US Registry. Am J Ind Med. 2020;63(2):115-20. Go to original source... Go to PubMed...
  27. Eurostat. Occupational diseases statistics [Internet]. Luxembourg: Eurostat, Statistics Explained; 2020 [cited 2021 Sep 3]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Occupational_diseases_statistics.
  28. Wilk E, Krówczyñska M. Malignant mesothelioma and asbestos exposure in Europe: Evidence of spatial clustering. Geospat Health. 2021;16(1). doi: 10.4081/gh.2021.951. Go to original source... Go to PubMed...
  29. Gilham C, Rake C, Hodgson J, Darnton A, Burdett G, Peto Wild J, et al. Past and current asbestos exposure and future mesothelioma risks in Britain: The Inhaled Particles Study (TIPS). Int J Epidemiol. 2018;47(6):1745-56. Go to original source... Go to PubMed...
  30. Jakubec P, Pelclova D, Smolkova P, Kolek V, Nakladalova M. Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(3):472-9. Go to original source... Go to PubMed...